150 related articles for article (PubMed ID: 12385926)
21. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy.
Cohen JK; Miller RJ; Ahmed S; Lotz MJ; Baust J
Urology; 2008 Mar; 71(3):515-8. PubMed ID: 18342200
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific antigen after cryosurgical ablation of the prostate. Defining the appropriate response.
Connolly JA; Shinohara K; Presti JC; Carroll PR
Urol Clin North Am; 1997 May; 24(2):415-20. PubMed ID: 9126239
[TBL] [Abstract][Full Text] [Related]
23. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.
Kollmeier MA; Stock RG; Stone N
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):645-53. PubMed ID: 14529768
[TBL] [Abstract][Full Text] [Related]
24. Outcome and safety of transrectal US-guided percutaneous cryotherapy for localized prostate cancer.
Saliken JC; Donnelly BJ; Brasher P; Ali-Ridha N; Ernst S; Robinson J
J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):199-208. PubMed ID: 10082109
[TBL] [Abstract][Full Text] [Related]
25. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.
Lambert EH; Bolte K; Masson P; Katz AE
Urology; 2007 Jun; 69(6):1117-20. PubMed ID: 17572198
[TBL] [Abstract][Full Text] [Related]
26. PSA elevation during prostate cryosurgery and subsequent decline.
Leibovici D; Zisman A; Lindner A; Stav K; Siegel YI
Urol Oncol; 2005; 23(1):8-11. PubMed ID: 15885576
[TBL] [Abstract][Full Text] [Related]
27. Increased serum total creatine kinase and creatine kinase isoenzyme MB after cryosurgical ablation of the prostate.
Long JP; Fallick ML; Rand W
J Urol; 1997 May; 157(5):1723-6. PubMed ID: 9112513
[TBL] [Abstract][Full Text] [Related]
28. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience.
Ghafar MA; Johnson CW; De La Taille A; Benson MC; Bagiella E; Fatal M; Olsson CA; Katz AE
J Urol; 2001 Oct; 166(4):1333-7; discussion 1337-8. PubMed ID: 11547068
[TBL] [Abstract][Full Text] [Related]
29. The feasibility and safety of repeat cryosurgical ablation of localized prostate cancer.
Mustafa M; Delacroix S; Ward JF; Pisters L
World J Surg Oncol; 2015 Dec; 13():340. PubMed ID: 26691335
[TBL] [Abstract][Full Text] [Related]
30. [Role of transrectal ultrasonography in the follow-up of patients treated with prostatic cryosurgery].
Galosi AB; Muzzonigro G; Polito M; Minardi D; Dellabella M; Lugnani F; Polito M
Arch Ital Urol Androl; 2000 Dec; 72(4):276-81. PubMed ID: 11221054
[TBL] [Abstract][Full Text] [Related]
31. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
[TBL] [Abstract][Full Text] [Related]
32. Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.
Kang SH; Kim JW; Bae JH; Park HS; Moon DG; Yoon DK; Cheon J; Kim JJ
Asian J Androl; 2006 Sep; 8(5):629-36. PubMed ID: 16847531
[TBL] [Abstract][Full Text] [Related]
33. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate.
D'amico AV; Tempany CM; Schultz D; Cormack RA; Hurwitz M; Beard C; Albert M; Kooy H; Jolesz F; Richie JP
Urology; 2003 Dec; 62(6):1063-7. PubMed ID: 14665356
[TBL] [Abstract][Full Text] [Related]
34. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience.
de la Taille A; Hayek O; Benson MC; Bagiella E; Olsson CA; Fatal M; Katz AE
Urology; 2000 Jan; 55(1):79-84. PubMed ID: 10654899
[TBL] [Abstract][Full Text] [Related]
35. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
deVere White RW; Hackman RM; Soares SE; Beckett LA; Li Y; Sun B
Urology; 2004 Feb; 63(2):259-63. PubMed ID: 14972467
[TBL] [Abstract][Full Text] [Related]
36. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
37. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.
Gonzalez CM; Roehl KA; Antenor JV; Blunt LW; Han M; Catalona WJ
Urology; 2004 Oct; 64(4):723-8. PubMed ID: 15491709
[TBL] [Abstract][Full Text] [Related]
38. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.
Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X
BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685
[TBL] [Abstract][Full Text] [Related]
39. Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate.
Cox RL; Crawford ED
Urology; 1995 Jun; 45(6):932-5. PubMed ID: 7771025
[TBL] [Abstract][Full Text] [Related]
40. Serum PSA evaluations during salvage radiotherapy for post-prostatectomy biochemical failures as prognosticators for treatment outcomes.
Do T; Dave G; Parker R; Kagan AR
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1220-5. PubMed ID: 11483332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
